$-4.41
(Market cap
$7 Mln
Revenue (TTM)
$438 Mln
P/E Ratio
--
P/B Ratio
1.2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-7 Mln
-
ROE
-0.8 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-3.9
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
14,889,900
6 Years Aggregate
CFO
$-26.38 Mln
EBITDA
$-28.16 Mln
Net Profit
$-30.84 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GBS (GBS)
| -86.6 | -49.9 | -51.9 | -87.9 | -- | -- | -- |
|
BSE Sensex*
| -9.3 | 2.1 | 3.0 | -5.3 | 6.9 | 7.8 | 11.1 |
|
Company
|
2022
|
2021
|
|---|---|---|
|
GBS (GBS)
| -80.1 | -80.6 |
|
BSE Sensex
| 4.4 | 22.0 |
|
BSE Sensex
| 4.4 | 22.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
GBS (GBS)
|
0.2 | 7.1 | 437.7 | -4.6 | -1.6 | -65.4 | -- | 1.2 |
| 281.9 | 37,764.0 | 4,286.9 | 577.2 | 20.3 | 88.2 | 70.9 | 35.1 | |
| 52.1 | 13,354.5 | 2,375.5 | 833.4 | 41.5 | 40.7 | 17.6 | 6.9 | |
| 127.3 | 17,452.8 | 1,080.2 | -433.2 | -39.8 | -- | -- | 55.7 | |
| 179.2 | 29,936.9 | 16,632.0 | 1,385.0 | 14.1 | 22.3 | 22.3 | 4.9 | |
| 501.2 | 11,084.5 | 1,132.5 | -309.4 | -25.0 | -52.9 | -- | 20.4 | |
| 461.6 | 13,347.1 | 2,678.3 | 460.4 | 21.3 | 103.2 | 29.4 | 22.3 | |
| 614.7 | 64,176.2 | 14,919.6 | 4,423.4 | 34.9 | 14.2 | 14.9 | 2.0 | |
| 548.3 | 23,174.2 | 3,169.8 | 1,287.4 | 51.3 | 20.6 | 20.2 | 3.9 | |
| 453.2 | 112,924.4 | 12,255.1 | 4,338.3 | 32.0 | 23.7 | 26.4 | 5.8 |
Shareholding Pattern
View DetailsAbout GBS (GBS)
GBS Inc. operates as a biosensor diagnostic technology company in the Asia-Pacific and North America. It offers Saliva Glucose Biosensor, an organic thin-film transistor for diabetes management that measures glucose in saliva. The company also... focuses on developing SARS-CoV-2 Biosensor, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. GBS Inc. has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. The company was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc. and changed its name to GBS Inc. in September 2019. The company was incorporated in 2016 and is headquartered in New York, New York. GBS Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd. Read more
-
Interim CEO & Chairman
Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D.
-
Interim CEO & Chairman
Dr. Stephen Constantine Boyages M.D., MBBS, Ph.D.
-
Headquarters
New York, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for GBS (GBS)
What is the current share price of GBS Inc (GBS) Today?
The share price of GBS Inc (GBS) is $0.19 (NASDAQ) as of 28-Dec-2022 09:30 EDT. GBS Inc (GBS) has given a return of -87.94% in the last 1 years.
What is the current PB & PE ratio of GBS Inc (GBS)?
Since, TTM earnings of GBS Inc (GBS) is negative, P/E ratio is not available.
The P/B ratio of GBS Inc (GBS) is 1.18 times as on 24-Jan-2023, a 71 discount to its peers’ median range of 4.14 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-1.17
|
1.47
|
|
2021
|
-6.60
|
3.09
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
What is the 52 Week High and Low of GBS Inc (GBS)?
The 52-week high and low of GBS Inc (GBS) are Rs -- and Rs -- as of 17-Jun-2026.
What is the market cap of GBS Inc (GBS)?
GBS Inc (GBS) has a market capitalisation of $ 7 Mln as on 24-Jan-2023. As per SEBI classification, it is a company.
Should I invest in GBS Inc (GBS)?
Before investing in GBS Inc (GBS), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.